Use of Berlin Heart EXCOR extracorporeal heart systems in patients with critical heart failure
https://doi.org/10.23873/2074-0506-2011-0-1-22-27
Abstract
The paper describes the experience of the A.N. Bakulev Research Center of Cardiovascular Surgery, Russian Academy of Medical Sciences, in using a Berlin Heart EXCOR extracorporeal heart system (Germany) to treat critical heart failure. Artificial heart ventricles (AHV) were implanted in 8 patients who were waiting for cardiac transplantation and had a limited probability of survival and unoperated defects. The main medical and technical characteristics of the systems and the patient’s clinical status in the preoperative and immediate and late postoperative periods are presented. Indications for and contraindication to implantation of the systems and their possible application modes are considered. Equipment and a procedure for AHV implantation in different positions of afflicted heart bypass are detailed. Approaches to postoperative management and treatment policy for postoperative complications are described in detail.
About the Authors
L. A. Bockeria
A.N. Bakulev Research Center of Cardiovascular Surgery, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
K. V. Shatalov
A.N. Bakulev Research Center of Cardiovascular Surgery, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
References
1. Adams J.F., Lindenfeld J., Arnold J. et al. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006;12:1-122.
2. Mehra M.R., Kobashigawa J., Starling R. et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006;25:1024-42.
3. Taylor D.O., Edwards L.B., Boucek M.M. et al. Registry of the International Society for Heart and Lung Transplantation: Twentythird Official Adult Heart Transplantation Report-2006, 11 July 2006. J Heart Transplant 2006;25:869-79.
4. 2006 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996-2005.
5. Available at: http://www.optn.org/AR2006/waitlist_outcomes.htm. Accessed July 27, 2007.
6. Current U.S. Waiting List for Heart Transplant Candidates. Based on OPTN data as of January 1, 2007.
7. Rose E., Gelijns A., Moskowitz A. et al. Long term use of left ventricular device forendstage heart failure. (REMATCH). N Engl J Med 2001;345:1435-43.
8. El-Banayosy A., Arusoglu L., Kizner L. et al. Novacor left ventricular assist system versus HeartMate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 2000;119:581-7.
9. Navia J.L., McCarthy P.M., Hoercher K.J. et al. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg 2002;74:2051-63.
10. Wilson S.R., Mudge G.H., Stewart G.C.,Givertz M.M. Evaluation for a ventricular assist device. Circulation 2009;119:2225-32.
11. Komoda T., Hetzer R., Lehmkuhl H.B. Destiny of candidates for heart transplantation in the Eurotransplant heart allocation system. Eur J Cardio-thor Surg 2008;34:301-6.
12. Бокерия Л.А., Шаталов К.В., Свободов А.А. Системы вспомогательного и заместительного кровообращения. М.: Изд-во НЦССХ им. А.Н. Бакулева РАМН, 2000; с. 31-33.
13. Шумаков В.И. Трансплантация сердца. М., 2006; с. 75-6.
Review
For citations:
Bockeria L.A., Shatalov K.V. Use of Berlin Heart EXCOR extracorporeal heart systems in patients with critical heart failure. Transplantologiya. The Russian Journal of Transplantation. 2011;(1):22-27. (In Russ.) https://doi.org/10.23873/2074-0506-2011-0-1-22-27
Views:
675
Email this article 